| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 85,607 | 82,330 | 88,937 | 112,781 | | Cost of Revenue | 76,061 | 74,133 | 77,706 | 99,392 | | | Gross Profit | 9,546 | 8,197 | 11,231 | 13,389 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,973 | 10,643 | 10,667 | 12,676 | | Non Recurring |
-
|
-
|
-
| 16,250 | | Others | 26 | 27 | 26 | 201 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (453) | (2,473) | 538 | (15,738) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 63 | | Earnings Before Interest And Taxes | (1,420) | (2,473) | 538 | (15,675) | | Interest Expense | (678) | 321 | 357 | 500 | | Income Before Tax | (742) | (2,794) | 181 | (16,175) | | Income Tax Expense | 104 | (265) | 429 | (1) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (846) | (2,529) | (248) | (16,174) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (846) | (2,529) | (248) | (16,174) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($846) | ($2,529) | ($248) | ($16,174) |
|
1.25% Nasdaq 
Income Statement
